Basal cell carcinoma (BCC) is the most common form of skin cancer, with an estimated 3.6 million cases diagnosed in the United States each year. It develops in the basal cells, which sit at the bottom of the outer layer of skin and continuously produce new skin cells as old ones die off. While BCC rarely spreads to other parts of the body, it can grow into surrounding tissue and cause significant damage if left untreated.
How Common It Really Is
Skin cancer is by far the most frequently diagnosed cancer in the United States, and BCC accounts for the largest share. Roughly 6.1 million adults are treated for basal cell and squamous cell carcinomas combined each year, at a cost of about $8.9 billion. Squamous cell carcinoma (SCC) is the second most common type, and while older teaching materials cite a 4:1 ratio of BCC to SCC, more recent data from Stanford Healthcare and Medicare records show the gap is narrower than previously thought, closer to 1.4 to 1. In people over 60, the ratio nearly equalizes, with BCC and SCC occurring at almost the same rate.
Melanoma, the type most people fear, is far less common than either BCC or SCC but is more dangerous because it spreads more readily. BCC sits at the opposite end of that spectrum: extremely common but rarely life-threatening.
What Causes It
The primary driver is cumulative exposure to ultraviolet (UV) radiation, particularly UVB rays from the sun. UV light damages DNA inside skin cells, and over time, those mutations can disrupt the signaling pathway that controls how basal cells grow and divide. In BCC specifically, mutations tend to corrupt a growth-regulating system called the Hedgehog pathway, which normally keeps cell production in check. When this pathway malfunctions, basal cells begin multiplying without the usual stop signals.
Tanning beds deliver the same type of UV damage and carry the same risk. A single severe sunburn, especially in childhood, increases risk later in life, but the day-to-day accumulation of sun exposure over decades is what drives most cases.
Who Is Most at Risk
Skin tone is the single biggest predictor of BCC risk. People with very fair skin that always burns and never tans (sometimes described as type 1 or type 2 on the Fitzpatrick scale) face the highest risk. Their skin produces less melanin, the pigment that absorbs UV radiation before it can reach deeper cell layers. People with medium skin tones who sometimes burn still face meaningful risk, and darkening after sun exposure is itself a sign of UV damage. Those with deeply pigmented skin rarely develop BCC, but it does happen, and tumors on darker skin are more likely to be diagnosed late because they’re harder to spot.
Other risk factors include a history of previous skin cancers, a weakened immune system, long-term exposure to radiation therapy, and a family history of skin cancer. BCC becomes more common with age simply because UV damage accumulates over a lifetime, which is why diagnosis rates climb steeply after age 50.
What It Looks Like
BCC doesn’t look the same on every person, and it can take several different forms. The most recognizable is a shiny, translucent bump with a pearly or waxy appearance. On lighter skin, it often looks pink or skin-colored. On brown or Black skin, it may appear brown or glossy black. Tiny blood vessels are sometimes visible on the surface of the bump, giving it a slightly reddish hue.
Not all BCCs are raised bumps, though. Some appear as flat, scaly patches with a slightly raised edge. Others look like white, waxy, scar-like areas without a clear border, which makes them easy to dismiss. A dark-colored lesion with a translucent, rolled border is another presentation, particularly on darker skin tones. One telltale sign across all types: the spot may bleed, scab over, heal partially, and then bleed again. Any sore that won’t fully heal within a few weeks deserves attention.
BCC most commonly appears on sun-exposed areas like the face, ears, neck, scalp, and shoulders, but it can develop anywhere on the body, including areas that rarely see sunlight.
How It’s Treated
The good news is that BCC is highly curable when caught early. Treatment depends on the tumor’s size, location, and whether it has recurred after a previous treatment.
For small, low-risk tumors, standard surgical excision (cutting the tumor out along with a margin of healthy tissue) is often sufficient. For larger tumors, tumors on the face, or those that have come back after prior treatment, Mohs surgery offers the highest cure rate of any approach. During Mohs, a surgeon removes thin layers of tissue one at a time, examining each under a microscope before deciding whether more needs to come out. This preserves as much healthy skin as possible, which matters in cosmetically sensitive areas like the nose, eyelids, and lips.
Smaller or superficial BCCs can sometimes be treated without surgery using topical creams that stimulate the immune system, cryotherapy (freezing the tumor), or photodynamic therapy, which uses a light-sensitive chemical and a special light to destroy abnormal cells. Your dermatologist will recommend the approach that balances cure rate with cosmetic outcome for your specific situation.
Recurrence and Long-Term Outlook
Once you’ve had one BCC, your risk of developing another one is significantly higher. Studies consistently show that people with a history of BCC are more likely to develop additional skin cancers within the next five years, including both new BCCs and squamous cell carcinomas. This doesn’t mean the original cancer has spread. It means the underlying UV damage to your skin has already set the stage for new tumors to form independently.
Regular skin checks become important after a diagnosis. A dermatologist will typically want to see you at least once a year, and more frequently in the first few years after treatment. Between appointments, monthly self-exams help catch new or changing spots early. If you have a large number of moles, atypical moles, or a family history of melanoma, more frequent professional evaluations are appropriate.
Reducing Your Risk
Most BCC is preventable. Daily broad-spectrum sunscreen with SPF 30 or higher on exposed skin, even on cloudy days, reduces cumulative UV damage. Reapply every two hours when outdoors, and more often if swimming or sweating. Protective clothing, wide-brimmed hats, and sunglasses with UV protection add another layer of defense. Seeking shade during peak UV hours (roughly 10 a.m. to 4 p.m.) makes a measurable difference over time.
Avoiding tanning beds eliminates one of the most concentrated sources of UV exposure. For people who want a tanned appearance, sunless tanning products offer a cosmetic alternative without the DNA damage. Starting these habits early in life has the greatest impact, but reducing UV exposure at any age slows the accumulation of mutations that lead to skin cancer.